Accurately Aligning Data Structures That Can Stand Up To Regulatory Scrutiny

Cmed's Data & Analytics team demonstrated their commitment to provide flexible and innovative solutions to meet the requirements of complex clinical trial situations
Situation
A biopharmaceutical company had an ongoing observational study with 120 patients in 5 sites. As the team started to plan their first Phase I study they realised that they wanted to align the data structures from both studies.
The observational study had been initiated in another EDC system but this was not a suitable solution for the sponsor. The preference was to adopt encapsia (Cmed's proprietary EDC and analytics platform) to take advantage of its advanced analytical capablity.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.